MA (EU) Numbers  (Invented) name  Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Pack size 
EU/1/19/1397/001 
EU/1/19/1397/002 
EU/1/19/1397/003 
Bortezomib 
Fresenius Kabi 
Bortezomib 
Fresenius Kabi 
Bortezomib 
Fresenius Kabi 
3.5 mg 
 1 mg 
2.5 mg 
Powder for solution 
for injection 
Intravenous use, 
Subcutaneous use 
vial (glass) 
1 vial 
Powder for solution 
for injection 
Powder for solution 
for injection 
Intravenous use 
vial (glass) 
Intravenous use, 
Subcutaneous use 
vial (glass) 
1 vial 
1 vial 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
